Achillion

The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
Achillion Hepatitis C Drug Trial on Hold on Liver Concern
Bloomberg
Tue, 07/2/13 - 01:25 am
Achillion
hepatitis C
sovaprevir
Achillion May Be The Most Underrated Biotech Left
Seeking Alpha
Wed, 06/26/13 - 09:35 am
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Vertex Pharmaceuticals
Indenix
ACH-3102
ACH-1625
hepatitis C
Biotechs Lose Ground As Achillion Takes a Dive
The Motley Fool
Sun, 06/16/13 - 11:33 am
biotech
Achillion
stock
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Achillion Names New CEO
Motley Fool
Wed, 05/29/13 - 09:01 am
Achillion
Pharma CEOs
Milind Deshpande
Achillion: Down But Not Out And Progress Being Made
Seeking Alpha
Fri, 05/10/13 - 01:39 pm
Achillion
Bristol-Myers Squibb
This Week in Biotech
Motley Fool
Sun, 04/28/13 - 12:13 pm
Avanir
Medivation
Pfizer
Achillion
Theravance
Gilead Sciences
GSK
Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients
Bloomberg
Tue, 04/23/13 - 07:57 am
hepatitis C
Achillion
ACH-3102
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
Tue, 04/16/13 - 11:55 am
sofosbuvir
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Merck
Idenix
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 04/6/13 - 10:49 am
Rigel Pharmaceuticals
Achillion
Halozyme
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Hepatitis C In Play for 2013?
Motley Fool
Wed, 02/27/13 - 11:24 am
hepatitis C
BMS-986094
Bristol-Myers Squibb
Gilead
Idenix
Incivek
Achillion
Vertex Pharmaceuticals
Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
Fri, 02/22/13 - 10:38 am
Achillion
AbbVie
JNJ
Gilead
Bristol-Myers Squibb
Life Sciences: Upcoming Events for Week of January 13
Motley Fool
Wed, 01/16/13 - 12:12 pm
Achillion
NuPathe
Anacor
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Achillion: Poised For Growth And Now Is The Time To Buy
Seeking Alpha
Wed, 01/2/13 - 11:47 am
Achillion
Abbott Labs
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Vertex Pharmaceuticals
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Invest in the Great Progress of Hepatitis C
Motley Fool
Sat, 12/8/12 - 11:17 am
hepatitis C
Gilead Sciences
sofosbuvir
Medivir
TMC435
ACH-1625
Achillion

Pages